ICU Medical (ICUI) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.96 per share a year ago.
ICU Medical unveils a strategic plan to offset new U.S. tariffs, aiming to protect margins and stability amid medtech market volatility and global trade shifts.
ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety.
ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Brett Fishbin - KeyBanc Capital Markets Charlie Strauzer - CJS Securities Michael Toomey - Jefferies Joseph Conway - Needham Operator Good day. And welcome to the ICU Medical, Inc. Fourth Quarter 2024 Earnings Conference Call.
ICU Medical (ICUI) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.57 per share a year ago.
ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond James Larry Solow - CJS Securities Kristen Stewart - CL King Mike Matson - Needham and Company Michael Toomey - Jefferies Operator Good day, everyone, and welcome to today's ICU Medical Inc.'s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago.
ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.